Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P49336: Variant p.Arg29Gly

Cyclin-dependent kinase 8
Gene: CDK8
Feedback?
Variant information Variant position: help 29 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glycine (G) at position 29 (R29G, p.Arg29Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In IDDHBA; decreased protein kinase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 29 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 464 The length of the canonical sequence.
Location on the sequence: help LSSERERVEDLFEYEGCKVG R GTYGHVYKAKRKDGKDDKDY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LSSERERVEDLFEYEGCK-VGRGTYGHVYKAKRKDGK---DDKDY

Mouse                         LSSERERVEDLFEYEGCK-VGRGTYGHVYKAKRKDGK---D

Xenopus laevis                LTGERERVEDLFEYEGCK-VGRGTYGHVYKAKRKDGK---D

Xenopus tropicalis            LTGERERVEDLFEYEGCK-VGRGTYGHVYKAKRKDGR---D

Zebrafish                     LTGERERVEDLFEYEGCK-VGRGTYGHVYKAKRKDGK---D

Caenorhabditis elegans        LAQRRERVEDLFYFENSKEIGRGTYGLVYKAVPKKQNGQFP

Drosophila                    TQIERTKVEDLFNYEGCK-VGRGTYGHVYKAKWKETS---D

Slime mold                    VQEKYT-----FSYE----IGSGTYGMVYKADDKKR----P

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 464 Cyclin-dependent kinase 8
Domain 21 – 335 Protein kinase
Binding site 27 – 35
Beta strand 26 – 30



Literature citations
De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder.
Calpena E.; Hervieu A.; Kaserer T.; Swagemakers S.M.A.; Goos J.A.C.; Popoola O.; Ortiz-Ruiz M.J.; Barbaro-Dieber T.; Bownass L.; Brilstra E.H.; Brimble E.; Foulds N.; Grebe T.A.; Harder A.V.E.; Lees M.M.; Monaghan K.G.; Newbury-Ecob R.A.; Ong K.R.; Osio D.; Reynoso Santos F.J.; Ruzhnikov M.R.Z.; Telegrafi A.; van Binsbergen E.; van Dooren M.F.; van der Spek P.J.; Blagg J.; Twigg S.R.F.; Mathijssen I.M.J.; Clarke P.A.; Wilkie A.O.M.;
Am. J. Hum. Genet. 104:709-720(2019)
Cited for: INVOLVEMENT IN IDDHBA; VARIANTS IDDHBA LEU-27; GLY-29; SER-30; LEU-62; LEU-97; GLN-178; GLY-193 AND MET-223; CHARACTERIZATION OF VARIANTS IDDHBA LEU-27; GLY-29; SER-30; LEU-62; GLN-178; GLY-193 AND MET-223; FUNCTION; MUTAGENESIS OF ASP-173;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.